สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์
Printed on 19 March 2025 19:14

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To
 Reset

NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED : NAM

The Financial Statements which need to be revised ( 0 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
Data not found
Finanacial Statements ( 14 record(s) found)
NameYearStatusTypePeriodAs OfDetails
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED2024AuditedConsolidatedYear31/12/2024
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED2024AuditedCompanyYear31/12/2024
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ330/09/2024
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED2024ReviewedCompanyQ330/09/2024
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ230/06/2024
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED2024ReviewedCompanyQ230/06/2024
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ131/03/2024
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED2024ReviewedCompanyQ131/03/2024
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED2023AuditedConsolidatedYear31/12/2023
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED2023AuditedCompanyYear31/12/2023
Click here to display all results
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 8 record(s) found)
DateTimeHeadingLink
03/03/202508:14Management Discussion and Analysis Yearly Ending 31 Dec 2024
14/11/202407:50Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024
14/08/202407:37Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
14/05/202407:20Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
27/02/202407:43Management Discussion and Analysis Yearly Ending 31 Dec 2023
14/11/202306:59Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023
30/10/202308:17Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023
30/10/202308:16Management Discussion and Analysis Yearly Ending 31 Dec 2022
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found
Last updated on 18 March 2025